BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 23970884)

  • 21. NLRPs, the subcortical maternal complex and genomic imprinting.
    Monk D; Sanchez-Delgado M; Fisher R
    Reproduction; 2017 Dec; 154(6):R161-R170. PubMed ID: 28916717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The spectrum of NLRP7 mutations in French patients with recurrent hydatidiform mole.
    Muhlstein J; Golfier F; Rittore C; Hajri T; Philibert L; Abel F; Beneteau C; Touitou I
    Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):197-9. PubMed ID: 21439709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent triploid and dispermic conceptions in patients with NLRP7 mutations.
    Slim R; Ao A; Surti U; Zhang L; Hoffner L; Arseneau J; Cheung A; Chebaro W; Wischmeijer A
    Placenta; 2011 May; 32(5):409-12. PubMed ID: 21421271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Family pedigree analysis in family member with history of hydatidiform mole and the NLRP7 gene expression].
    Li Y; Cheng Q; Qian JH; Zhou W; Xie X; Slim R
    Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):600-4. PubMed ID: 22169519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of recurrent molar pregnancies following complete and partial hydatidiform moles.
    Eagles N; Sebire NJ; Short D; Savage PM; Seckl MJ; Fisher RA
    Hum Reprod; 2015 Sep; 30(9):2055-63. PubMed ID: 26202916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent pregnancy loss in a woman with NLRP7 mutation: not all molar pregnancies can be easily classified as either "partial" or "complete" hydatidiform moles.
    Brown L; Mount S; Reddy R; Slim R; Wong C; Jobanputra V; Clifford P; Merrill L; Brown S
    Int J Gynecol Pathol; 2013 Jul; 32(4):399-405. PubMed ID: 23722513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent complete hydatidiform mole: where we are, is there a safe gestational horizon? Opinion and mini-review.
    Kalogiannidis I; Kalinderi K; Kalinderis M; Miliaras D; Tarlatzis B; Athanasiadis A
    J Assist Reprod Genet; 2018 Jun; 35(6):967-973. PubMed ID: 29737470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel NLRP7 protein-truncating mutation associated with discordant and divergent p57 immunostaining in diploid biparental and triploid digynic moles.
    Allias F; Mechtouf N; Gaillot-Durand L; Hoffner L; Hajri T; Devouassoux-Shisheboran M; Massardier J; Golfier F; Bolze PA; Surti U; Slim R
    Virchows Arch; 2020 Aug; 477(2):309-315. PubMed ID: 32055942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NLRP7 and the genetics of post-molar choriocarcinomas in Senegal.
    Slim R; Coullin P; Diatta AL; Chebaro W; Courtin D; Abdelhak S; Garcia A
    Mol Hum Reprod; 2012 Jan; 18(1):52-6. PubMed ID: 21948117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of 13 novel NLRP7 mutations in 20 families with recurrent hydatidiform mole; missense mutations cluster in the leucine-rich region.
    Wang CM; Dixon PH; Decordova S; Hodges MD; Sebire NJ; Ozalp S; Fallahian M; Sensi A; Ashrafi F; Repiska V; Zhao J; Xiang Y; Savage PM; Seckl MJ; Fisher RA
    J Med Genet; 2009 Aug; 46(8):569-75. PubMed ID: 19246479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An analysis of the influences of maternal age, gestational age, contraceptive method, and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy.
    Stone M; Bagshawe KD
    Br J Obstet Gynaecol; 1979 Oct; 86(10):782-92. PubMed ID: 228696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NLRP7 mutations in women with diploid androgenetic and triploid moles: a proposed mechanism for mole formation.
    Deveault C; Qian JH; Chebaro W; Ao A; Gilbert L; Mehio A; Khan R; Tan SL; Wischmeijer A; Coullin P; Xie X; Slim R
    Hum Mol Genet; 2009 Mar; 18(5):888-97. PubMed ID: 19066229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reprogramming of human peripheral blood mononuclear cells from a patient suffering from recurrent hydatidiform mole to an iPSC line FAHZUi001-A carrying a homozygous p.Gln421Ter mutation in NLRP7 gene.
    Gong T; Wang H; Huang B; Wang H; Zhang P; Qian J
    Stem Cell Res; 2021 May; 53():102361. PubMed ID: 34087990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for NLRP7 mutations in familial and sporadic recurrent hydatidiform moles: report of 2 Tunisian families.
    Landolsi H; Rittore C; Philibert L; Missaoui N; Hmissa S; Touitou I; Gribaa M; Yacoubi MT
    Int J Gynecol Pathol; 2011 Jul; 30(4):348-53. PubMed ID: 21623199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NLRP7 Promotes Choriocarcinoma Growth and Progression through the Establishment of an Immunosuppressive Microenvironment.
    Reynaud D; Abi Nahed R; Lemaitre N; Bolze PA; Traboulsi W; Sergent F; Battail C; Filhol O; Sapin V; Boufettal H; Hoffmann P; Aboussaouira T; Murthi P; Slim R; Benharouga M; Alfaidy N
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34203890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A recurrent intragenic genomic duplication, other novel mutations in NLRP7 and imprinting defects in recurrent biparental hydatidiform moles.
    Kou YC; Shao L; Peng HH; Rosetta R; del Gaudio D; Wagner AF; Al-Hussaini TK; Van den Veyver IB
    Mol Hum Reprod; 2008 Jan; 14(1):33-40. PubMed ID: 18039680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pregnancy after oocyte donation in a patient with NLRP7 gene mutations and recurrent molar hydatidiform pregnancies.
    Cozette C; Scheffler F; Lombart M; Massardier J; Bolze PA; Hajri T; Golfier F; Touitou I; Rittore C; Gondry J; Merviel P; Benkhalifa M; Cabry R
    J Assist Reprod Genet; 2020 Sep; 37(9):2273-2277. PubMed ID: 32592075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic mapping of a maternal locus responsible for familial hydatidiform moles.
    Moglabey YB; Kircheisen R; Seoud M; El Mogharbel N; Van den Veyver I; Slim R
    Hum Mol Genet; 1999 Apr; 8(4):667-71. PubMed ID: 10072436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of NLRP7 in Normal and Malignant Trophoblast Cells.
    Abi Nahed R; Elkhoury Mikhael M; Reynaud D; Collet C; Lemaitre N; Michy T; Hoffmann P; Sergent F; Marquette C; Murthi P; Raia-Barjat T; Alfaidy N; Benharouga M
    Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans.
    Murdoch S; Djuric U; Mazhar B; Seoud M; Khan R; Kuick R; Bagga R; Kircheisen R; Ao A; Ratti B; Hanash S; Rouleau GA; Slim R
    Nat Genet; 2006 Mar; 38(3):300-2. PubMed ID: 16462743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.